Legal 500

  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers

  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…

  • In-House

    • In-House Content
    • GC Powerlist

  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments

    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers

  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…

  • In-House

    • In-House Content
    • GC Powerlist

  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments

    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

344 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

    The time and financial expense of bringing a novel drug to market is enormous and the process is fraught with risk. Very often, a putative novel chemical entity showing promising...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Dehns
    Dehns
  • Article

    The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

    Methods for treatment of the human or animal body by therapy (or surgery) are excluded from patent protection at the EPO under Article 53(c) EPC.
    United StatesFood, Drugs, Healthcare, Life Sciences
Dehns
Dehns
  • Article

    How Should Brand Owners Approach The Legal And Reputational Impacts Of Taking Action To Protect Their Trade Marks?

    Social media presents brand owners with both opportunities and risks that must be carefully navigated if a brand is to succeed in the 21st century.
    United KingdomIntellectual Property
    Dehns
    Dehns
  • Article

    UK Patent Fees To Increase From 6 April 2018 - What This Means For Your Business

    On 6 April 2018, the UK Intellectual Property Office is making small increases to most of its fees.
    United KingdomIntellectual Property
    Dehns
    Dehns

    • Showing 341–344 of 344 results

    Previous
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics